Description
The investments under Mission 6 are divided into 2 Components:
- Component 1 - Neighbourhood networks, facilities and telemedicine for territorial health care, which aims at enhancing protection from environmental and climatic health risks and better responding to community needs for treatment and care at the local level
- Component 2 - Innovation, Research and Digitisation of the Health Service, which aims to ensure the necessary conditions for greater resilience of the National Health Service through the replacement of obsolete health technologies in hospitals, the development of significant structural improvement in the safety and security of hospital buildings, the improvement of information systems and digital health tools, the promotion and strengthening of the scientific research sector and the strengthening of human resources
On27 May 2022 (Resolution No. 972 of 27 May 2022), the outline of the Institutional Development Agreement (CIS) between the Autonomous Province of Trento and the Ministry of Health was approved and the Provincial Operational Plan (POP) was re-approved, for its signature and transmission to the Ministry.
The POP - Provincial Operational Plan for the implementation of the PNRR Mission 6 interventions was approved by Resolution No. 696/2022 of the Provincial Council, and amended by Resolutions No. 972/2022, No. 2072/2023 and No. 973/2024.
For information on initiatives at national level, see the websites Italia Domani, Ministry of Health - PNRR and Agenas (National Agency for Regional Health Services).
Projects
Projects of other actors in the area and other investments
The aim is to strengthen the biomedical research system through two lines of action:
funding Proof of Concept (PoC) projects, supporting the development of technologies with a low degree of technological maturity and promoting technology transfer to industry
the funding of research programmes or projects in the field of rare diseases, rare cancers and other highly disabling diseases.
The aim of the intervention is to strengthen Italian research groups at the forefront of diagnostics, developing an integrated approach based on molecular biomarkers and advanced imaging to develop personalised and innovative medicine for early diagnosis, prevention and drug monitoring in human diseases.
Read more